Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19)

Study on the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030832

Enrollment

Unknown

Registered

2020-03-15

Start date

2020-03-16

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 1:mindfulness therapy

Group 2:cognitive behavioral therapy

Group 3:exercise therapy

Group 4:Without treatment, online assessment per two weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Intervention group: (1) Aged 18 to 50 years; (2) Diagnosed as a depression or anxiety by Diagnostic and Statistical Manual of Mental Disorders (DSM-5); the score of HAMD-17>17,or HAMA>7; 2. Non-intervention group: (1) Aged 18 to 50 years; (2) Diagnosed as a depression or anxiety by Diagnostic and Statistical Manual of Mental Disorders (DSM-5); the score of HAMD-17>17,or HAMA>7.

Exclusion criteria

Exclusion criteria: (1) other psychiatric disorders; (2) complicating with sever medical disorder on nervous, cardiovascular, respiratory system; (3) taking antidepressants, psychoactive drugs, steroids, drugs that affect heart rate and blood pressure; (4) be in the Lactation or pregnancy.

Design outcomes

Primary

Measure	Time frame
PHQ-9;GAD-7;PHQ-15;PSS-14;ISI;SHARPS;ACTH;cortisol;24-hour ECG;Magnetic resonance spectroscopy;	—

Contacts

Public ContactYuan Yang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology(HUST)

yuanyang70@hotmail.com+86 13995561816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026